Related Experiment Videos
Summary
This study found that mexiletine, diazepam, and betahistine did not reduce tinnitus loudness in patients. The trial was stopped due to safety concerns with mexiletine, a cardiovascular drug used for a non-cardiovascular condition.
Area of Science:
- Otolaryngology
- Clinical Pharmacology
Background:
- Tinnitus is a common condition affecting many individuals.
- Current treatments for tinnitus have limited efficacy.
- Mexiletine, an antiarrhythmic drug, was investigated for potential tinnitus relief.
Purpose of the Study:
- To evaluate the efficacy of mexiletine, diazepam, and betahistine in reducing tinnitus loudness.
- To assess the safety profile of these medications in a tinnitus patient population.
Main Methods:
- A double-blind, triple cross-over trial involving 21 tinnitus patients.
- Sequential administration of mexiletine, diazepam, betahistine, and placebo for one month each.
- Subjective tinnitus loudness recorded using a visual analogue scale.
Main Results:
- None of the tested medications (mexiletine, diazepam, betahistine) significantly influenced tinnitus loudness.
- The trial was halted prematurely due to safety concerns regarding mexiletine, including a reported vasovagal attack in a separate study.
- Cardiovascular risks associated with mexiletine led to the exclusion of 21 out of 42 potential participants.
Conclusions:
- Mexiletine, diazepam, and betahistine are not effective treatments for reducing tinnitus loudness.
- Using cardiovascular drugs like mexiletine for non-cardiovascular conditions like tinnitus poses significant safety risks.
- Further research into safer and more effective tinnitus treatments is warranted.